Uterine transposition in a patient with vulvar cancer
Objective: To report the first uterine transposition for fertility preservation in a patient with vulvar cancer.Case: A 26-year-old nulliparous patient with stage IIIB vulvar cancer, which was resected with adequate margins and bilateral inguinofemoral lymphadenectomy.Laparoscopic transposition of t...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Gynecologic Oncology Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S235257892400016X |
_version_ | 1797234352237576192 |
---|---|
author | Joel Laufer Santiago Scasso Dana Kimelman Clara Olmedo Valeria Bentancor Anne Soust Gonzalo Sotero Reitan Ribeiro |
author_facet | Joel Laufer Santiago Scasso Dana Kimelman Clara Olmedo Valeria Bentancor Anne Soust Gonzalo Sotero Reitan Ribeiro |
author_sort | Joel Laufer |
collection | DOAJ |
description | Objective: To report the first uterine transposition for fertility preservation in a patient with vulvar cancer.Case: A 26-year-old nulliparous patient with stage IIIB vulvar cancer, which was resected with adequate margins and bilateral inguinofemoral lymphadenectomy.Laparoscopic transposition of the uterus to the upper abdomen, outside of the scope of radiation was performed to preserve fertility and ovarian function. After the end of radiotherapy, the uterus was repositioned into the pelvis.Main Outcome Measure: Uterine and ovarian function preservation. Result: The patient recovered her menstrual cycles spontaneously 1 month after the reimplantation and exhibited normal variation in ovarian hormones.Twelve months after the surgery, the uterus was normal and there was no sign of recurrent disease. Conclusion: Uterine transposition might represent a valid option for fertility preservation in women who require pelvic radiotherapy. However, studies that assess its viability, effectiveness, and safety are required. |
first_indexed | 2024-03-07T23:22:02Z |
format | Article |
id | doaj.art-9eded6b34c0842c883e6fc56b6fded75 |
institution | Directory Open Access Journal |
issn | 2352-5789 |
language | English |
last_indexed | 2024-04-24T16:30:42Z |
publishDate | 2024-04-01 |
publisher | Elsevier |
record_format | Article |
series | Gynecologic Oncology Reports |
spelling | doaj.art-9eded6b34c0842c883e6fc56b6fded752024-03-30T04:39:21ZengElsevierGynecologic Oncology Reports2352-57892024-04-0152101337Uterine transposition in a patient with vulvar cancerJoel Laufer0Santiago Scasso1Dana Kimelman2Clara Olmedo3Valeria Bentancor4Anne Soust5Gonzalo Sotero6Reitan Ribeiro7Department of Gynecology C, Universidad de la República, Montevideo, Uruguay; Corresponding autor at: Bonpland 629, 11300 Montevideo, Uruguay.Department of Gynecology, British Hospital, Montevideo, UruguayOncofertility Program. Hospital Pereira Rossell, ASSE, Montevideo, UruguayDepartment of Gynecology C, Universidad de la República, Montevideo, UruguayDepartment of Gynecology C, Universidad de la República, Montevideo, UruguayDepartment of Gynecology C, Universidad de la República, Montevideo, UruguayDepartment of Gynecology C, Universidad de la República, Montevideo, UruguayDepartment of Surgical Oncology, Erasto Gaertner Hospital, Curitiba, BrazilObjective: To report the first uterine transposition for fertility preservation in a patient with vulvar cancer.Case: A 26-year-old nulliparous patient with stage IIIB vulvar cancer, which was resected with adequate margins and bilateral inguinofemoral lymphadenectomy.Laparoscopic transposition of the uterus to the upper abdomen, outside of the scope of radiation was performed to preserve fertility and ovarian function. After the end of radiotherapy, the uterus was repositioned into the pelvis.Main Outcome Measure: Uterine and ovarian function preservation. Result: The patient recovered her menstrual cycles spontaneously 1 month after the reimplantation and exhibited normal variation in ovarian hormones.Twelve months after the surgery, the uterus was normal and there was no sign of recurrent disease. Conclusion: Uterine transposition might represent a valid option for fertility preservation in women who require pelvic radiotherapy. However, studies that assess its viability, effectiveness, and safety are required.http://www.sciencedirect.com/science/article/pii/S235257892400016XUterine transpositionVulvar cancerPelvic radiotherapyFertility preservation |
spellingShingle | Joel Laufer Santiago Scasso Dana Kimelman Clara Olmedo Valeria Bentancor Anne Soust Gonzalo Sotero Reitan Ribeiro Uterine transposition in a patient with vulvar cancer Gynecologic Oncology Reports Uterine transposition Vulvar cancer Pelvic radiotherapy Fertility preservation |
title | Uterine transposition in a patient with vulvar cancer |
title_full | Uterine transposition in a patient with vulvar cancer |
title_fullStr | Uterine transposition in a patient with vulvar cancer |
title_full_unstemmed | Uterine transposition in a patient with vulvar cancer |
title_short | Uterine transposition in a patient with vulvar cancer |
title_sort | uterine transposition in a patient with vulvar cancer |
topic | Uterine transposition Vulvar cancer Pelvic radiotherapy Fertility preservation |
url | http://www.sciencedirect.com/science/article/pii/S235257892400016X |
work_keys_str_mv | AT joellaufer uterinetranspositioninapatientwithvulvarcancer AT santiagoscasso uterinetranspositioninapatientwithvulvarcancer AT danakimelman uterinetranspositioninapatientwithvulvarcancer AT claraolmedo uterinetranspositioninapatientwithvulvarcancer AT valeriabentancor uterinetranspositioninapatientwithvulvarcancer AT annesoust uterinetranspositioninapatientwithvulvarcancer AT gonzalosotero uterinetranspositioninapatientwithvulvarcancer AT reitanribeiro uterinetranspositioninapatientwithvulvarcancer |